Scientific Update on Bruton Tyrosine Kinase Inhibitors to Improve Outcomes for Patients with Multiple Sclerosis

Nov 23, 2022

- Nov 22, 2023

0.75

Claim your AMA PRA Category 1 Credit(s) credit

Already have an Account? Log In
Don’t have an account? Register Today

This course is available for logged in users only. Please login or register to take the course.

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeuti...

Update on Advanced Treatment Plans to Improve Outcomes for Patients with Primary Biliary C...

Update From ESC24: New Data on Non-Statin Lipid Lowering Therapies and Reduced CV Risk